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ZnO acts as a recyclable heterogeneous catalyst to afford the products in excellent yield in short reaction
duration.
 2012 Elsevier Ltd. All rights reserved.In recent years, the growing environmental concern in chemis-
try has turned the spotlight on multicomponent reactions as the
new trend in organic chemistry.1 Multicomponent reactions
(MCRs) are very important for the construction of many heterocy-
clic compounds,2 using this strategy many biologically active sub-
stances and natural products have been synthesized.3
The synthesis of nitrogen heterocycles is of great interest
because they constitute an important class of natural and synthetic
products, many of which exhibit useful biological activity and ﬁnd
application in pharmaceutical preparations.4–7
The quinoline ring system is an important structural unit in
many naturally occurring alkaloids, therapeutics, and in the syn-
thetic analogues with interesting biological activities.8 Quinolines
are also very important for designing many pharmacologically
important compounds,9 due to their wide spectrum of biological
activities such as antimalarial, anti-bacterial, anti-asthmatic, anti-
hypertensive, anti-inﬂammatory, anti-platelet, and tyrokinase
PDGF-RTK inhibiting activities.10–12 Therefore, the development
of new and efﬁcient methodologies for the synthesis of quinoline
ring system will be interesting in both synthetic organic and
medicinal chemistry.13 Methods for the synthesis of the quinoline
ring system have been developed and documented in the litera-
ture.14 However, most of these methods are not completely satis-
factory with regard to the yield and reaction conditions. Hence, all rights reserved.
.
).simple and an efﬁcient method for the synthesis of the quinolone
ring system is still in demand.
Recently, the heterogeneous catalysis has developed consider-
able interest in the various disciplines of science including organic
synthesis due to the prime advantage that, in most of the cases the
heterogeneous catalysts can be recovered with only minor change
in activity and selectivity so that they can be used in continuous
ﬂow reactions.15 Heterogeneous catalysts have many advantages
over their homogeneous counterparts.
In continuation of our efforts to develop new methods for the
synthesis of biologically active heterocyclic compounds using
readily available, inexpensive, and environment friendly cata-
lysts,16–22 herein, we wish to report a mild and efﬁcient method
for the synthesis23 of some novel 4-aryl-2,5-dioxo-1,2,3,4,5,6,7,8-
octahydroquinoline-3-carboxylic acid ethyl esters. This method
utilizes a one-pot four-component reaction of aromatic aldehydes,
diethyl malonate, dimedone/1,3-cyclohexadione, and ammonium
acetate in the presence of readily available, inexpensive, mild,
recyclable, and common laboratory chemical ZnO as a catalyst
(Scheme 1).
An initial study was performed by treating a mixture of anisal-
dehyde, diethyl malonate, dimedone, and ammonium acetate in
water without any catalyst similar to the reaction which was car-
ried out to get N-amino derivative of substituted quinoline-2,5-
dione as one of the intermediates in a multistep reaction,24 and
found that, the reaction was possible in water under reﬂux, and
the isolated yield after 8 h was low (45%, Table 2, entry 1). When
Table 1
Inﬂuence of various catalysts on the synthesis of octahydroquinolindiones
Entry Catalysta Time (h) Yieldb(%)
1 AmberliteIR120 Hc 13 20
2 CeCl3 12 30
3 ZnCl2 10 35
4 K2CO3 6 40
5 Ba(OH)2 6 70
6 ZnO 2 90




Effect of solvent on the synthesis of octahydroquinolindiones
Entry Solvent (reﬂux) Time(h) Yielda (%)
1 EtOH 4 65
2 MeOH 5 70
3 CH3CN 6 55
4 H2O 2 90
a Isolated yield.
Table 4
Synthesis of octahydroquinolindiones catalyzed by ZnO in water
Entry Aldehydes Producta Time (h) Yieldb (%) Mp oC
1 4-MeOC6H4CHO 5a 2 90 145–147
2 3,4-(MeO)2C6H3CHO 5b 2.5 85 160–163
3 2-HOC6H4CHO 5c 2.5 87 230–232
4 3-NO2C6H4CHO 5d 2 90 168–170
5 2-NO2C6H4CHO 5e 2 88 173–175
6 4-ClC6H4CHO 5f 2.5 86 238–240
7 HCHO 5g 15 ND —
8 CH3CHO 5h 15 ND —
9 3-NO2C6H4CHO 5ic 10 40 186–189
a All isolated products are new and were characterized by IR, 1H NMR, 13C NMR
spectral and CHN analyses.
b Isolated yields.
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Scheme 1. Synthesis of octahydroquinolindiones.
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the yield was again 45% (isolated yield) after 15 h (Table 2, entry
2). As the reaction requires a catalyst, we performed the reaction
using Amberlite IR-120H (0.1 g), 30 mol % acidic (CeCl3, ZnCl2,)
and basic catalysts (K2CO3, Ba(OH)2, ZnO). We found that, ZnO is
best in terms of yield and duration of reaction (Table 1, entry 6).
ZnO has earlier been shown to be a mild base and ﬁnds application
in organic synthesis.25
Further, studies were carried out to optimize the amount of cat-
alyst by using different amounts of ZnO (3, 5, 6, 7.5, 10, 15, and
30 mol %) and the results are presented in Table 2; we found that,
7.5 mol % of ZnO affords the product in 90% isolated yield. Increas-
ing the amount of catalyst did not improve the yield (Table 2).
It was noticed that, the reaction is also possible by ZnO in
reﬂuxing EtOH, MeOH, and CH3CN; among the solvents used H2O
was found to be the best solvent as shown in Table 3.
To demonstrate the generality of this method, we performed all
further reactions using ZnO (7.5 mol %) in water at reﬂux, and
found that, ZnO can efﬁciently catalyze the reaction between dime-
done, diethyl malonate, ammonium acetate, and different aromatic
aldehydes to afford excellent yield of the desired products within
2–2.5 h. When we carried out the reaction using aliphatic
aldehydes, there was no product formation even after 15 h (Table
4, entries 7,8). We also examined the use of 1,3-cyclohexandione
instead of dimedone (Table 4, entry 9) and found that, the reactionTable 2











1 0 10 2 8 45
2 0 10 3 15 45
3 3 10 2 15 60
4 3 10 2 3 50
5 5 10 2 3 60
6 6 10 2 2 75
7 7.5 10 2 2 90
8 10 10 2 2 90
9 15 10 2 2 90
10 30 10 2 2 89
a Isolated yield.works but the isolated yield after 10 h is only 40%. From Table 4, it
is clear that, the method is equally effective for both electron with-
drawing and electron donating aromatic aldehydes.
In recent years, Raman spectroscopy has been proved to be a
valuable tool in the investigation of structure of complex mole-
cules of biological interest.26 Recently, we have reported the vibra-
tional studies on 6-amino-4-(40-methoxyphenyl)-5-cyano-3-
methyl-1-phenyl-1,4-dihydropyrano[2,3-c]pyrazole.27
To determine the conﬁguration of C15 (C4) and C16 (C3) in 4-
(20-nitrophenyl)-7,7-dimethyl-2,5-dioxo-1,2,3,4,5,6,7,8-octahydro-
quinoline-3-carboxylic acid ethyl ester (5e), the vibrational
frequencies were calculated and the scaled values were compared
with experimental FT-IR and FT-Raman spectral values for both cis-
and trans- isomers to ﬁnd the structure of 5e. It is found that, the
observed and the calculated frequencies of e,e0-trans- isomer are
found to be in good agreement for the important functional groups
as shown in Table 5. These frequency calculations were carried out
on the optimized structure of 5e using the program available in the
GAUSSIAN software.28–30
The optimized geometry of 5e and the numbering system is
given in Figure 1. From the density functional theory (DFT) calcu-
lations we found that, the conﬁguration of C15 (C4) and C16 (C3)
in 5e is ee0-trans.
The possibility of recycling the catalyst was then examined.
After completion of the reaction (2–2.5 h), the contents were
ﬁltered and dichloromethane (10 ml) was added to the residue,
Figure 2. Reusability of ZnO in the synthesis of octahydroquinolindiones.
Figure 1. Optimized structure of 5e.
Table 5
Comparison of some important computed and experimental vibrational frequencies of cis- and trans-5e
Serial no. Functional group Calculated frequency m cm1 trans Exptl. FT-IRa m cm1 Exptl. FT-Ramana m cm1 Calculated frequency m cm1 cis
1 C@O(pyridine) 1618 1617 1616 1715
2 C@O (Ester) 1718 1721 1723 1697
3 C15-H19 (str) 2921 2922 2916 2949
4 C16-H50 (str) 2973 2961 2952 3018
a (FT-IR and FT-Raman spectra are available as supplementary data).
6308 S. H. S. Azzam et al. / Tetrahedron Letters 53 (2012) 6306–6309the catalyst was ﬁltered and washed with dichloromethane and
recycled ﬁve times. From the Figure 2, it can be seen that, in the
ﬁrst four runs the activity was more or less maintained but after
the fourth run it starts decreasing, which is due to loss of the cat-
alyst during recovery and the recovered amount of catalyst is
0.025, 0.024, 0.023, 0.022, and 0.020 g and the respective isolated
yields for the ﬁve runs is found to be 90%, 89%, 87%, 85%, and 78%.
In conclusion, we have developed a new, rapid, and efﬁcient
method for the synthesis of 4-aryl-2,5-dioxo-1,2,3,4,5,6,7,8-octa-
hydroquinoline-3-carboxylic acid ethyl esters by a one-pot four
component reaction of aromatic aldehydes, diethyl malonate,
dimedone/1,3-cyclohexadione, and ammonium acetate using ZnO
as an efﬁcient, mild, and heterogeneous catalyst which could be re-
used for at least ﬁve times. The reaction is facile, simple, and envi-
ronment-friendly.
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112.2 (all ArC), 112.2 (OC–C@C), 55.6 (O–CH2), 52.8 (O–CH3), 47.5 (O@C–CH–
C@O), 46.9 (CH2), 41.2 (CH2), 32.4 (C@C–CH), 31.8 (>C<), 30.2, 27.8 (CH3), 18.8
(CH3); Anal. Calcd for C21H25N1O5: C, 67.91; H, 6.78; N, 3.77%. Found: C, 67.91;
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5b: Mp 160-163 C; IR (KBr): m 3398 (br), 2962 (s), 1733(s), 1705 (s), 1668 (s),
1615 (vs), 1514 (s), 1448 (s), 1375 (vs), 1240 (vs), 1147 (vs), 1027 (s) cm1; 1H
NMR (400 MHz, CDCl3): d 1.11 (s, 6H, 2Me), 1.23 (t, J = 5.2 Hz, 3H, Me), 2.35
(s,2H, CH2), 2.40 (s, 2H, CH2), 3.76 (s, 3H, CH3), 3.84 (s, 3H, CH3), 3.98 (q,
J = 5.2 Hz, 2H, CH2), 4.15 (d, J = 7.2 Hz,1H, CH), 5.48 (d, J = 7.2 Hz,1H, CH), 6.61
(s, 1H, Ph), 6.62 (d, J = 8.0 Hz, 1H, Ph), 6.76 (d, J = 8.0 Hz, 1H, Ph), 10.99 (s, 1H,NH); 13C NMR (100 MHz, CDCl3): d 190.9 (C@O), 179.8 (NC@O), 160.0 (OC@O),
147.4 (NC@C), 130.8, 122.8, 119.3, 116.2, 111.2, 110.8 (all ArC), 110.8 (OC–
C@C), 61.8 (O–CH2), 56.2 (O–CH3), 56.1 (O–CH3), 47.5 (O@C–CH–C@O), 47.5
(CH2), 46.8 (CH2), 32.7 (C@C–CH), 31.7 (>C<), 30.4, 27.5 (CH3), 17.8 (CH3); Anal.
Calcd for C22H27N1O6: C, 65.82; H, 6.78; N, 3.49%. Found: C, 65.82; H, 6.782; N,
3.49%.
5c: Mp 230–232 C; IR (KBr): m 3433 (br), 3232 (br), 2954 (s), 1734 (s), 1705 (s),
1668 (s), 1615 (vs), 1517 (s), 1448 (s), 1375 (vs), 1244 (s), 1135 (vs), 1037 (s)
cm1; 1H NMR (400 MHz, CDCl3): d 1.11 (s, 6H, 2Me), 1.23 (t, J = 5.2 Hz, 3H,
Me), 2.35 (s,2H, CH2), 2.40 (s, 2H, CH2), 3.93 (q, J = 7.2 Hz, 2H, CH2), 4.07 (d,
J = 7.2 Hz,1H, CH), 4.57 (s, 1H, OH), 5.28 (d, J = 7.2 Hz, 1H, CH), 6.99 (d,
J = 5.6 Hz, 1H, Ph), 7.13 (d, J = 5.6 Hz, 1H, Ph),7.37 (d, J = 7.6 Hz, 1H, Ph), 7.41 (d,
J = J = 7.6 Hz, 1H, Ph), 10.49 (br, 1H, NH); 13C NMR (100 MHz, CDCl3): d 201.5
(C@O), 187.1 (NC@O), 169.1 (OC@O), 151.5 (NC@C), 128.4, 128.0, 125.0, 124.7,
118.7, 116.2 (all ArC), 111.4 (OC–C@C), 50.3 (O–CH2), 43.6 (O@C–CH–C@O),
42.0 (CH2), 31.4 (CH2), 30.4 (C@C–CH), 29.6 (>C<), 28.2, 26.8 (CH3), 17.1 (CH3);
Anal. Calcd for C20H23N1O5: C, 67.21; H, 6.49; N, 3.92%. Found: C, 67.20; H,
6.461; N, 3.91%.
5d: Mp 168–170 C; IR (KBr): m 3433 (br), 2960 (s),1737(s), 1705 (s), 1668 (s),
1615 (vs), 1527 (s), 1448 (s), 1377 (vs), 1336 (vs)1253 (s), 1166 (s), 1022 (s)
cm1; 1H NMR (400 MHz, CDCl3): d 1.11 (s, 6H, 2Me), 1.23 (t, J = 5.2 Hz, 3H,
Me), 2.35 (s,2H, CH2), 2.40 (s, 2H, CH2), 4.09 (q, J = 6.0 Hz, 2H, CH2), 4.38 (d,
J = 6 Hz,1H, CH), 5.54 (d, J = 7.2 Hz,1H, CH), 7.40–7.44 (m, 2H, Ph), 8.00–8.04
(m, 2H, Ph), 10.96 (s, 1H, NH); 13C NMR (100 MHz, CDCl3): d 191.3 (C@O), 180.9
(NC@O), 159.1 (OC@O), 137.5 (NC@C), 137.5, 132.5, 131.8, 130.0, 127.8, 124.6
(all ArC), 115.1 (OC–C@C), 57.8 (O–CH2), 47.3 (O@C–CH–C@O), 46.7 (CH2), 32.3
(CH2), 30.5 (C@C–CH), 29.0 (>C<), 28.6, 26.0 (CH3), 15.1 (CH3); Anal. Calcd for
C20H22N2O6: C, 62.17; H, 5.74; N, 7.25%. Found: C, 62.17; H, 5.741; N, 7.25%.
5e: Mp 173–175 C; IR (KBr): m 3433 (br), 2960 (s),1730 (s), 1705 (s), 1668 (s),
1615 (vs), 1523 (vs), 1448 (s), 1388 (s), 1367(s), 1238 (s), 1135 (vs), 1058 (s)
cm1; 1H NMR (400 MHz, CDCl3): d 1.11 (s, 6H, 2Me), 1.23 (t, J = 5.2 Hz, 3H,
Me), 2.35 (s,2H, CH2), 2.40 (s, 2H, CH2), 4.09 (q, J = 6.0 Hz, 2H, CH2), 4.45 (d,
J = 6.8 Hz,1H, CH), 6.05 (d, J = 6.8 Hz, 1H, CH), 7.24 (d, J = 7.6 Hz, 1H, Ph), 7.03
(d, J = 7.6 Hz, 1H, Ph), 7.44 (d, J = 8.0 Hz, 1H, Ph), 7.47 (d, J = 8.0 Hz, 1H, Ph),
10.86 (s, 1H, NH); 13C NMR (100 MHz, CDCl3): d 191.6 (C@O), 178.1 (NC@O),
161.8 (OC@O), 148.8 (NC@C), 141.1, 133.3, 129.5, 122.7, 121.5, 115.2 (all ArC),
115.2 (OC–C@C), 54.8 (O–CH2), 47.4 (O@C–CH–C@O), 46.8 (CH2), 32.3 (CH2),
31.9 (C@C–CH), 30.1 (>C<), 27.6, 26.1 (CH3), 16.2 (CH3); Anal. Calcd for
C20H22N2O6: C, 62.17; H, 5.74; N, 7.25%. Found: C, 62.17; H, 5.741; N, 7.24%.
5f: Mp 238–240 C; IR (KBr): m 3431 (br), 2956 (s),1734 (s), 1704 (s), 1668 (s),
1615 (vs), 1498 (s), 1396 (s), 1257 (s), 1135 (s), 1020 (s),827 (vs) cm1; 1H NMR
(400 MHz, CDCl3): d 1.11 (s, 6H, 2Me), 1.23 (t, J = 5.2 Hz, 3H, Me), 2.55 (s,2H,
CH2), 2.67 (s, 2H, CH2), 3.98 (q, J = 6 Hz, 2H, CH2), 4.16 (d, J = 7.2 Hz, 1H, CH),
5.48 (d, J = 7.2 Hz, 1H, CH), 7.00–7.02 (m, 2H, Ph), 7.21–7.23 (m, 2H, Ph), 10.87
(br, 1H, NH); 13C NMR (100 MHz, CDCl3): d 191.4 (C@O), 176.9 (NC@O), 160.9
(OC@O), 148.8 (NC@C), 131.4, 129.9, 128.8, 128.6, 117.8, 110.2 (all ArC), 110.2
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